D2S Pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
D2S Pharma
Largest movements
- Stocks and contracts +€50,945
up €50,945 (+27.7%), from €183,978 to €234,923
- Cash +€46,493
up €46,493 (+32.7%), from €142,011 to €188,504
mainly Depreciation (+€40,299) and Net result for the year (+€38,474)
- Tangible fixed assets -€32,662
down €32,662 (-28.9%), from €113,000 to €80,338
of which Plant, machinery and equipment: -€28,068
- Receivables within one year -€18,335
down €18,335 (-27.4%), from €67,002 to €48,666
of which Trade receivables: -€17,387
- Profit (loss) carried forward +€38,474
up €38,474 (+13.4%), from €286,223 to €324,697
- Trade debts +€27,888
up €27,888 (+99.4%), from €28,048 to €55,936
- Debts after one year -€9,503
down €9,503 (-13.7%), from €69,503 to €60,000
- Gross operating margin +€18,120
up €18,120 (+16.3%), from €111,075 to €129,195
- Taxes +€7,387
up €7,387 (+100.5%), from €7,353 to €14,740
- Staff costs -€5,166
down €5,166 (-16.1%), from €32,075 to €26,909
- Other operating charges -€2,459
down €2,459 (-23.6%), from €10,433 to €7,974
- Depreciation -€1,637
down €1,637 (-3.9%), from €41,936 to €40,299
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €536,409 | €582,318 | +€45,909 | +8.6% |
| Fixed assets | 21/28 | €137,559 | €100,573 | -€36,986 | -26.9% |
| Intangible fixed assets | 21 | €16,871 | €12,547 | -€4,324 | -25.6% |
| Tangible fixed assets | 22/27 | €113,000 | €80,338 | -€32,662 | -28.9% |
| Plant, machinery and equipment | 23 | €91,423 | €63,355 | -€28,068 | -30.7% |
| Furniture and vehicles | 24 | €4,304 | €2,337 | -€1,967 | -45.7% |
| Other tangible fixed assets | 26 | €17,273 | €14,646 | -€2,627 | -15.2% |
| Financial fixed assets | 28 | €7,688 | €7,688 | = | 0.0% |
| Current assets | 29/58 | €398,851 | €481,746 | +€82,895 | +20.8% |
| Stocks and contracts in progress | 3 | €183,978 | €234,923 | +€50,945 | +27.7% |
| Stocks | 30/36 | €183,978 | €234,923 | +€50,945 | +27.7% |
| Amounts receivable within one year | 40/41 | €67,002 | €48,666 | -€18,335 | -27.4% |
| Trade receivables | 40 | €66,053 | €48,666 | -€17,387 | -26.3% |
| Other amounts receivable | 41 | €949 | - | -€949 | |
| Cash at bank and in hand | 54/58 | €142,011 | €188,504 | +€46,493 | +32.7% |
| Deferred charges and accrued income | 490/1 | €5,860 | €9,652 | +€3,792 | +64.7% |
| Total equity and liabilities | 10/49 | €536,409 | €582,318 | +€45,909 | +8.6% |
| Equity | 10/15 | €386,223 | €424,697 | +€38,474 | +10.0% |
| Contributions | 10/11 | €100,000 | €100,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €286,223 | €324,697 | +€38,474 | +13.4% |
| Amounts payable | 17/49 | €150,186 | €157,621 | +€7,435 | +5.0% |
| Amounts payable after more than one year | 17 | €69,503 | €60,000 | -€9,503 | -13.7% |
| Financial debts | 170/4 | €69,503 | €60,000 | -€9,503 | -13.7% |
| Amounts payable within one year | 42/48 | €76,950 | €94,337 | +€17,387 | +22.6% |
| Current portion of amounts payable after more than one year | 42 | €14,156 | €9,503 | -€4,653 | -32.9% |
| Financial debts | 43 | - | €3 | +€3 | |
| Credit institutions | 430/8 | - | €3 | +€3 | |
| Trade debts | 44 | €28,048 | €55,936 | +€27,888 | +99.4% |
| Suppliers | 440/4 | €28,048 | €55,936 | +€27,888 | +99.4% |
| Taxes, remuneration and social security | 45 | €10,300 | €9,154 | -€1,146 | -11.1% |
| Taxes | 450/3 | €5,917 | €5,236 | -€682 | -11.5% |
| Remuneration and social security | 454/9 | €4,383 | €3,919 | -€464 | -10.6% |
| Other amounts payable | 47/48 | €24,445 | €19,740 | -€4,706 | -19.2% |
| Accrued charges and deferred income | 492/3 | €3,733 | €3,285 | -€449 | -12.0% |
| Remuneration, social security and pensions | 62 | €32,075 | €26,909 | -€5,166 | -16.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €41,936 | €40,299 | -€1,637 | -3.9% |
| Other operating charges | 640/8 | €10,433 | €7,974 | -€2,459 | -23.6% |
| Gross operating margin | 9900 | €111,075 | €129,195 | +€18,120 | +16.3% |
| Operating profit (loss) | 9901 | €26,631 | €54,013 | +€27,382 | +102.8% |
| Financial income | 75/76B | €1,552 | €1,667 | +€115 | +7.4% |
| Recurring financial income | 75 | €1,552 | €1,667 | +€115 | +7.4% |
| Financial charges | 65/66B | €3,125 | €2,466 | -€659 | -21.1% |
| Recurring financial charges | 65 | €3,125 | €2,466 | -€659 | -21.1% |
| Profit (loss) for the period before taxes | 9903 | €25,058 | €53,214 | +€28,157 | +112.4% |
| Income taxes | 67/77 | €7,353 | €14,740 | +€7,387 | +100.5% |
| Profit (loss) for the period | 9904 | €17,705 | €38,474 | +€20,769 | +117.3% |
| Profit (loss) for the period to be appropriated | 9905 | €17,705 | €38,474 | +€20,769 | +117.3% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.